• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质母细胞瘤中 microRNA 的系统评价:在间充质样迁移和侵袭模式中的 micro 调节剂。

A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion.

机构信息

Department of Biomedicine, Institute for Medicine and Health Technology, Aalborg University, Fredrik Bajers Vej 3B, 9220, Aalborg Øst, Denmark.

出版信息

Mol Neurobiol. 2013 Feb;47(1):131-44. doi: 10.1007/s12035-012-8349-7. Epub 2012 Oct 2.

DOI:10.1007/s12035-012-8349-7
PMID:23054677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3538124/
Abstract

Glioblastoma multiforme (GBM) is an incurable form of brain cancer with a very poor prognosis. Because of its highly invasive nature, it is impossible to remove all tumor cells during surgical resection, making relapse inevitable. Further research into the regulatory mechanism underpinning GBM pathogenesis is therefore warranted, and over the past decade, there has been an increased focus on the functional role of microRNA (miRNA). This systematic review aims to present a comprehensive overview of all the available literature on the expression profiles and function of miRNA in GBM. Here, we have reviewed 163 papers and identified 253 upregulated, 95 downregulated, and 17 disputed miRNAs with respect to expression levels; 85 % of these miRNAs have not yet been functionally characterized. A focus in this study has been 26 interesting miRNAs involved in the mesenchymal mode of migration and invasion, demonstrating the importance of miRNAs in the context of the cellular niche. Both oncogenic and tumor-suppressive miRNAs were found to affect target genes involved in cell migration, cytoskeletal rearrangement, invasiveness, and angiogenesis. Clearly, the distinct functional properties of these miRNAs need further investigation and might hold a great potential in future molecular therapies targeting GBM.

摘要

多形性胶质母细胞瘤(GBM)是一种无法治愈的脑癌,预后非常差。由于其高度侵袭性,在手术切除过程中不可能清除所有肿瘤细胞,因此复发是不可避免的。因此,有必要进一步研究支持 GBM 发病机制的调控机制,在过去的十年中,人们越来越关注 microRNA(miRNA)的功能作用。本系统评价旨在全面概述 GBM 中 miRNA 表达谱和功能的所有可用文献。在这里,我们回顾了 163 篇论文,确定了 253 个上调、95 个下调和 17 个有争议的 miRNA 的表达水平;其中 85%的 miRNA 尚未进行功能表征。本研究的重点是 26 种与间充质样迁移和侵袭模式相关的有趣 miRNA,这些 miRNA 证明了 miRNA 在细胞生态位中的重要性。致癌和肿瘤抑制 miRNA 都被发现影响参与细胞迁移、细胞骨架重排、侵袭性和血管生成的靶基因。显然,这些 miRNA 的独特功能特性需要进一步研究,并且在未来针对 GBM 的分子治疗中可能具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0052/3538124/d48627d88a2b/12035_2012_8349_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0052/3538124/5e37819649d9/12035_2012_8349_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0052/3538124/d48627d88a2b/12035_2012_8349_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0052/3538124/5e37819649d9/12035_2012_8349_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0052/3538124/d48627d88a2b/12035_2012_8349_Fig2_HTML.jpg

相似文献

1
A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion.胶质母细胞瘤中 microRNA 的系统评价:在间充质样迁移和侵袭模式中的 micro 调节剂。
Mol Neurobiol. 2013 Feb;47(1):131-44. doi: 10.1007/s12035-012-8349-7. Epub 2012 Oct 2.
2
The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation.胶质母细胞瘤中的上皮间质转化样过程:一项更新的系统评价和计算机模拟研究。
Med Res Rev. 2017 Mar;37(2):271-313. doi: 10.1002/med.21408. Epub 2016 Sep 12.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.在没有明显临床指征的患者和常见合并症患者亚组中,在择期手术前常规检测全血细胞计数、电解质和尿素以及肺功能测试的价值:对临床和成本效益文献的系统评价。
Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches.一种提高多形性胶质母细胞瘤治疗效果的新方法:非编码RNA靶向治疗及辅助方法。
Clin Epigenetics. 2025 Jun 21;17(1):108. doi: 10.1186/s13148-025-01900-5.
7
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
The role of ALDH1A1 in glioblastoma proliferation and invasion.ALDH1A1 在神经胶质瘤增殖和侵袭中的作用。
Chem Biol Interact. 2024 Oct 1;402:111202. doi: 10.1016/j.cbi.2024.111202. Epub 2024 Aug 10.

引用本文的文献

1
Unveiling cell-type-specific microRNA networks through alternative polyadenylation in glioblastoma.通过胶质母细胞瘤中的可变多聚腺苷酸化揭示细胞类型特异性微小RNA网络
BMC Biol. 2025 Jan 21;23(1):15. doi: 10.1186/s12915-024-02104-8.
2
Angiogenesis inhibitors effects on overall survival and progression-free survival in newly diagnosed primary glioblastoma multiforme: a meta-analysis of twelve randomized clinical trials.血管生成抑制剂对新诊断的多形性胶质母细胞瘤患者总生存期和无进展生存期的影响:十二项随机临床试验的荟萃分析
J Neurooncol. 2025 Jan;171(2):313-328. doi: 10.1007/s11060-024-04865-2. Epub 2024 Dec 5.
3
The Correlation Patterns of miRNA Expression with Targeted mRNA Transcripts in Glioma Patients with Wild-Type and Mutated Isocitrate Dehydrogenase (IDH) Genotypes.

本文引用的文献

1
The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity.上皮-间充质转化的调控:调节上皮可塑性的全局调控程序。
Semin Cancer Biol. 2012 Oct;22(5-6):361-8. doi: 10.1016/j.semcancer.2012.05.003. Epub 2012 May 18.
2
Current trends in targeted therapies for glioblastoma multiforme.多形性胶质母细胞瘤靶向治疗的当前趋势
Neurol Res Int. 2012;2012:878425. doi: 10.1155/2012/878425. Epub 2012 Mar 5.
3
Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme.多次显微手术切除治疗复发性多形性胶质母细胞瘤。
野生型和异柠檬酸脱氢酶(IDH)基因突变型胶质瘤患者中miRNA表达与靶向mRNA转录本的相关性模式
Acta Naturae. 2024 Jul-Sep;16(3):38-45. doi: 10.32607/actanaturae.27363.
4
Genomic, epigenomic and transcriptomic landscape of glioblastoma.胶质母细胞瘤的基因组、表观基因组和转录组景观。
Metab Brain Dis. 2024 Dec;39(8):1591-1611. doi: 10.1007/s11011-024-01414-8. Epub 2024 Aug 24.
5
Unraveling the noncoding RNA landscape in glioblastoma: from pathogenesis to precision therapeutics.解析胶质母细胞瘤中的非编码 RNA 图谱:从发病机制到精准治疗。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec;397(12):9475-9502. doi: 10.1007/s00210-024-03265-7. Epub 2024 Jul 15.
6
Polyphenols Modulate the miRNAs Expression that Involved in Glioblastoma.多酚调节涉及神经胶质瘤的 miRNAs 表达。
Mini Rev Med Chem. 2024;24(21):1953-1969. doi: 10.2174/0113895575304605240408105201.
7
Non-coding RNAs as Key Regulators of the Notch Signaling Pathway in Glioblastoma: Diagnostic, Prognostic, and Therapeutic Targets.非编码 RNA 作为胶质母细胞瘤 Notch 信号通路的关键调控因子:诊断、预后和治疗靶点。
CNS Neurol Disord Drug Targets. 2024;23(10):1203-1216. doi: 10.2174/0118715273277458231213063147.
8
Current knowledges in pharmaconutrition: "" in pediatric gliomas.药物营养的当前知识:小儿神经胶质瘤中的“” 。 (注:原文中“”部分内容缺失,翻译只能到这里)
Front Nutr. 2023 Aug 8;10:1222908. doi: 10.3389/fnut.2023.1222908. eCollection 2023.
9
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy.乳腺癌:微小RNA监测化疗耐药性及全身治疗
Front Oncol. 2023 Jun 16;13:1155254. doi: 10.3389/fonc.2023.1155254. eCollection 2023.
10
Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles?涉及多形性胶质母细胞瘤放射抵抗的分子途径:细胞外囊泡的作用是什么?
Int J Mol Sci. 2023 Mar 2;24(5):4883. doi: 10.3390/ijms24054883.
Am J Clin Oncol. 2013 Jun;36(3):261-8. doi: 10.1097/COC.0b013e3182467bb1.
4
Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines.连续选择侵袭性增加胶质母细胞瘤细胞系中 miR-143/miR-145 的表达。
BMC Cancer. 2012 Apr 10;12:143. doi: 10.1186/1471-2407-12-143.
5
miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.miR-34a 在神经前体细胞恶性胶质瘤中的抑制作用上调了其靶基因 PDGFRA 的表达,促进了肿瘤的发生。
PLoS One. 2012;7(3):e33844. doi: 10.1371/journal.pone.0033844. Epub 2012 Mar 27.
6
MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.miR-483-5p 通过直接靶向 ERK1 抑制神经胶质瘤细胞的增殖。
FEBS Lett. 2012 May 7;586(9):1312-7. doi: 10.1016/j.febslet.2012.03.035. Epub 2012 Mar 27.
7
MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1.miR-128 通过靶向 p70S6K1 抑制肿瘤生长和血管生成。
PLoS One. 2012;7(3):e32709. doi: 10.1371/journal.pone.0032709. Epub 2012 Mar 19.
8
MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme.胶质母细胞瘤中的 microRNAs/TP53 反馈回路。
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5316-21. doi: 10.1073/pnas.1202465109. Epub 2012 Mar 19.
9
miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.miR-137 在神经胶质瘤中经常下调,是 Cox-2 的负调控因子。
Eur J Cancer. 2012 Nov;48(16):3104-11. doi: 10.1016/j.ejca.2012.02.007. Epub 2012 Mar 7.
10
Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3.miR-125b在新的、具有高度侵袭性的胶质瘤干细胞和祖细胞系SU3中的表达。
Chin J Cancer. 2012 Apr;31(4):207-14. doi: 10.5732/cjc.011.10336. Epub 2012 Feb 24.